p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer.
Luo J, Chen Z, Qiao Y, Ching-Yi Tien J, Young E, Mannan R, Mahapatra S, He T, Eyunni S, Zhang Y, Zheng Y, Su F, Cao X, Wang R, Cheng Y, Seri R, George J, Shahine M, Miner SJ, Vaishampayan U, Wang M, Wang S, Parolia A, Chinnaiyan AM.
Luo J, et al. Among authors: young e.
bioRxiv [Preprint]. 2024 Mar 30:2024.03.29.587346. doi: 10.1101/2024.03.29.587346.
bioRxiv. 2024.
PMID: 38586029
Free PMC article.
Preprint.